Two decades of research in Salford are reflected in a new European clinical practice summary on atherosclerotic renovascular disease (ARVD), the most common type of renal artery stenosis.
Our expertise in this condition, which carries a high risk for future cardiovascular and renal problems, has been led by Professor Philip Kalra (pictured) and involved eight renal trainees undertaking a PhD or MD in the renal department. Four of these – Prof Darren Green, Dr Tina Chrysochou, Dr Jim Ritchie and Dr Aine de Bhailis – are now consultant colleagues here.
Experts from the European Renal Best Practice board of the European Renal Association and from the Working Group on Hypertension and the Kidney of the European Society of Hypertension have put together the recommendations. They summarise current knowledge in epidemiology, pathophysiology and diagnostic assessment of ARVD and present key evidence relevant to treatment and management.
The work is built on 148 papers in leading science journals, with 16 (11%) of them originating from our renal department or involving guidelines and randomized multi-centre trials in which the Salford team have played a leading role.